Analyzing the mechanisms responsible for hypercalcemia in all cancer types, PTHrP was present in 27% of cases, while osteolytic metastases were observed in 50%, 1,25-OH vitamin D was associated with approximately 39% of all cases (Figure 1). Here, PTHLH is linked to hypercalcemia disease.